The career platform for psychedelic medicine

Jobs, clinical trials, company intelligence, and state-by-state legal status for psychedelic medicine, tracked from primary sources.

36
Companies tracked
150
Open positions
1,553
Active clinical trials
17
States with legislation
Marissa Raymond-Flesch, MD, MPHPsilocybin · Anorexia NervosaPhase 2·
Theresa Jacob, PhD, MPHnebulized ketamine · Severe DepressionPhase 3·
RemedyMDMA · Post Traumatic Stress DisorderPhase 2·
Rennes University HospitalDMT withdrawal · Multiple SclerosisPhase 3·
Charles RaisonPsilocybin · DepressionPhase 2·
Alan DavisBiospecimen · Lung Non-Small Cell CarcinomaPhase 2·
Definium Therapeutics US, Inc.MM120 · Generalized Anxiety DisorderPhase 3·
Abraham NunesKetamine · Treatment Resistant DepressionPhase 3·
National Institute on Aging (NIA)Psilocybin · Alzheimer's DiseasePhase 2·
University Health Network, TorontoSingle · Major Depressive DisorderPhase 2·
Marissa Raymond-Flesch, MD, MPHPsilocybin · Anorexia NervosaPhase 2·
Theresa Jacob, PhD, MPHnebulized ketamine · Severe DepressionPhase 3·
RemedyMDMA · Post Traumatic Stress DisorderPhase 2·
Rennes University HospitalDMT withdrawal · Multiple SclerosisPhase 3·
Charles RaisonPsilocybin · DepressionPhase 2·
Alan DavisBiospecimen · Lung Non-Small Cell CarcinomaPhase 2·
Definium Therapeutics US, Inc.MM120 · Generalized Anxiety DisorderPhase 3·
Abraham NunesKetamine · Treatment Resistant DepressionPhase 3·
National Institute on Aging (NIA)Psilocybin · Alzheimer's DiseasePhase 2·
University Health Network, TorontoSingle · Major Depressive DisorderPhase 2·

Latest clinical trials

View all trials →

Stay ahead of the industry

Get updates on new job listings, clinical trial progress, and regulatory changes across all 50 states.